FDA-Drug2013-11-27Class II
Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
Boehringer Ingelheim Roxane Inc
Hazard
Resuspension Problems: Recalled lot did not meet resuspendability requirements.
Sold states
Nationwide
Affected count
10,267 bottles
Manufactured in
1809 Wilson Rd, Columbus, OH, United States
Products
Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-002-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief